Vision-Sciences Announces Peer-Reviewed Publication of Clinical Study Utilizing Its EndoSheath(R) Technology to Diagnose Esophageal Disease
May 17, 2012 16:15 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 17, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Record Revenue of $4.6 Million for Fourth Quarter and $16.7 Million for Full Year Fiscal 2012
May 15, 2012 07:00 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 15, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2012 Results
May 08, 2012 16:15 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., May 8, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences Announces Purchase Agreement for up to $15 Million With Lincoln Park Capital Fund, LLC
April 27, 2012 16:44 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., April 27, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable...
Vision-Sciences, Inc. to Present at Lazard Healthcare Conference on November 16, 2011
November 10, 2011 16:22 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced that executive management will present at the Lazard Capital Markets Healthcare Conference to be...
Vision-Sciences, Inc. Announces Net Sales Growth of 73% to $4.0 Million for the Second Quarter of Fiscal 2012
November 07, 2011 16:15 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its second quarter and first half of fiscal 2012, ended September 30, 2011....
Vision-Sciences, Inc. Schedules Second Quarter and First Half of Fiscal 2012 Conference Call for November 8, 2011
November 02, 2011 16:29 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) will issue financial results for the second quarter and first half of fiscal 2012, ended September 30, 2011,...
Vision-Sciences' Pioneering Technology Featured on The Doctor Oz Show
September 19, 2011 09:30 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today that its unique, advanced Transnasal EndoSheath® Esophagoscopy system will be featured on...
Vision-Sciences, Inc. Appoints Cynthia F. Ansari Chief Executive Officer
August 10, 2011 16:30 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) announced today that its Board of Directors has named Cynthia F. Ansari as Chief Executive Officer and elected...
Vision-Sciences, Inc. Announces $3.8 Million in Revenue for the First Quarter of Fiscal 2012
August 10, 2011 16:30 ET
|
Vision-Sciences, Inc.
ORANGEBURG, N.Y., Aug. 10, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) today announced financial results for its first quarter of fiscal 2012, ended June 30, 2011. For the first...